Repeated administration of trimethoprim/sulfadiazine in the horse--pharmacokinetics, plasma protein binding and influence on the intestinal microflora. 1999

A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
Department of Large Animal Clinical Sciences, Faculty of Veterinary Medicine, Swedish University of Agricultural Sciences, Uppsala.

Six healthy adult horses were given repeated administrations of trimethoprim/ sulfadiazine (TMP/SDZ) intravenously (i.v.) (2.5 mg/kg TMP and 12.5 mg/kg SDZ) and orally (p.o.) as a paste (5 mg/kg TMP and 25 mg/kg SDZ). Both formulations were given twice daily for 5 days, with a 3-week interval between i.v. and oral administration. The influence of the drug combination on the intestinal microflora was examined and the plasma concentrations, pharmacokinetic parameters and plasma protein binding were determined. There were no major changes in the bacterial intestinal flora and no clinical evidence of gastrointestinal disturbances following the i.v. and oral TMP/SDZ administration. An initial reduction in the number of coliform bacteria during the treatment was notable, though with no evident difference between i.v. and oral treatment. The minimum concentration during a dose interval at steady state (Cminss), the elimination half-life (t1/2beta) and the mean residence time (MRT) were significantly greater after oral administration compared to i.v. for both TMP and SDZ. The plasma protein binding was measured to be 20% for SDZ and 35% for TMP. Oral administration of TMP/SDZ in a dose of 30 mg/kg given twice daily in the form of paste appeared as a satisfactory method for obtaining plasma levels above MIC (minimum inhibitory concentration in vitro) values during the interdosing interval.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008297 Male Males
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic

Related Publications

A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
December 2017, International journal of antimicrobial agents,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
December 1986, Journal of veterinary pharmacology and therapeutics,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
November 1981, American journal of veterinary research,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
June 1981, American journal of veterinary research,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
November 1978, European journal of clinical pharmacology,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
December 1994, Journal of veterinary pharmacology and therapeutics,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
April 1983, American journal of veterinary research,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
December 2020, Journal of veterinary pharmacology and therapeutics,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
September 1974, British journal of pharmacology,
A Gustafsson, and V Båverud, and A Franklin, and A Gunnarsson, and G Ogren, and C Ingvast-Larsson
June 2009, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!